- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06682208
ES Catheter vs Cryoablation After Pectus Surgery
September 17, 2025 updated by: Children's Hospital Medical Center, Cincinnati
Prospective Randomized Trial of Efficacy and Safety of Erector Spinae Catheter and Intercostal Nerve Cryoablation Protocols After Pectus Surgery
Participants will be randomized to receive ES catheter or cryoablation for pain management after the Nuss procedure. The goal of this study is to compare the following between the two groups:
- Time to achieve short-term physical therapy goals and long-term functional outcomes
- Compare immediate and long-term postoperative opioid use
- Compare numbness on chest of postoperative day 1 and the return of sensation to baseline
- Compare the incidence of neuropathic pain and other complications
Participants will receive surveys for up to 12 months postoperatively.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
176
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kristie Geisler, BS
- Phone Number: 513-636-3282
- Email: kristie.geisler@cchmc.org
Study Contact Backup
- Name: Charlotte Walter, MD
- Phone Number: 513-636-4408
- Email: charlotte.walter@cchmc.org
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229
- Recruiting
- Cincinnati Children's Hospital Medical Center
-
Contact:
- Kristie Geisler, BS
- Phone Number: 513-636-3282
- Email: kristie.geisler@cchmc.org
-
Contact:
- Charlotte Walter, MD
- Phone Number: 513-636-4408
- Email: charlotte.walter@cchmc.org
-
Principal Investigator:
- Charlotte Walter, MD
-
Principal Investigator:
- Surya Narayanasamy, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 12 - 21 years
- History of pectus excavatum
- Scheduled for Nuss procedure
Exclusion Criteria:
- Prior pectus repair
- Other concomitant surgeries
- Chronic pain conditions including Ehlers Danlos Syndrome
- Non-English speaking - rationale: the questionnaires used in the study are in English language and the social and cultural factors of pain perception of non-English speaking patients could affect the study power
- Severe developmental delays including cognitive (difficulties understanding), motor (cerebral palsy or muscular dystrophy), and speech delays (difficulties communicating)
- History of or active renal or liver disease
- Major surgery requiring opioids in the last 2 years
- Severe respiratory problems (such as obstructive sleep apnea, cystic fibrosis, pulmonary fibrosis, or pneumonia within the last month)
- Cardiac conditions including, but not limited to, cyanotic heart disease, hypoplastic left ventricle, arrhythmia, uncontrolled hypertension with ongoing treatment, Kawasaki disease, or cardiomyopathies. Participants with asymptomatic valvular lesions or defects may be included
- BMI >35
- Pregnant or breastfeeding females
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: ES Catheter
Hospital procedure for ES catheters will be followed for postoperative pain.
|
ES catheter for postoperative pain control
|
|
Active Comparator: Intercostal Nerve Cryoablation (INC)
Hospital procedure for intercostal nerve cryoablation will be followed for postoperative pain.
|
INC used for postoperative pain control
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compare time to reach discharge
Time Frame: Day of surgery up tp 10 days post-operative
|
Comparing physical therapy goals to meet discharge criteria.
|
Day of surgery up tp 10 days post-operative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Opioid consumption
Time Frame: Day of surgery to up to one year
|
Comparing opioid consumption
|
Day of surgery to up to one year
|
|
Numbness on chest
Time Frame: Day of surgery and post-operative day 1
|
An exam glove with ice will used on the anterior axillary line to obtain a rating of the sensation felt. 0 - no sensation
|
Day of surgery and post-operative day 1
|
|
Neuropathic pain
Time Frame: Pre-operative, 6 weeks, 2-3 months, 4-6 months and 10-12 months post-operatively
|
Surveys will be used to compare the incidence of neuropathic pain
|
Pre-operative, 6 weeks, 2-3 months, 4-6 months and 10-12 months post-operatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Charlotte Walter, MD, Children's Hospital Medical Center, Cincinnati
- Principal Investigator: Surya Narayanasamy, MD, Children's Hospital Medical Center, Cincinnati
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 8, 2024
Primary Completion (Estimated)
April 1, 2029
Study Completion (Estimated)
April 1, 2029
Study Registration Dates
First Submitted
November 7, 2024
First Submitted That Met QC Criteria
November 8, 2024
First Posted (Actual)
November 12, 2024
Study Record Updates
Last Update Posted (Estimated)
September 18, 2025
Last Update Submitted That Met QC Criteria
September 17, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-0760
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pectus Excavatum
-
Hacettepe UniversityCompletedFunnel Chest | Pectus Excavatum | Pectus Excavatum Deformity | Chest DeformitiesTurkey
-
Galderma R&DPharma Consulting Group ABCompletedPectus Excavatum DeformityFrance, Sweden
-
Children's Health System, Inc.Walter Lorenz Surgical CorporationUnknownRepair of Pectus ExcavatumUnited States, Canada
-
Erik de LoosCompleted
-
Ankara Etlik City HospitalRecruitingPectus Excavatum DeformityTurkey (Türkiye)
-
Acibadem UniversityUnknownPhysical Disability | Psychosocial Impairment | Pectus DeformityTurkey
-
University Hospital, Strasbourg, FranceRecruiting
-
Başakşehir Çam & Sakura City HospitalRecruitingPectus ExcavatumTurkey
-
Zuyderland Medisch CentrumUnknownPectus ExcavatumNetherlands
-
Baylor College of MedicineTerminatedPectus ExcavatumUnited States
Clinical Trials on ES catheter
-
University of LiverpoolActive, not recruiting
-
Pamukkale UniversityNot yet recruitingUrinary Incontinence | ProstatectomyTurkey
-
Swiss Paraplegic Centre NottwilCompletedOrthostatic Hypotension | Spinal Cord InjurySwitzerland
-
Pamukkale UniversityRecruitingUrinary Bladder, OveractiveTurkey (Türkiye)
-
Ottawa Heart Institute Research CorporationRecruitingCardiac DiseaseCanada
-
Tarbiat Modarres UniversityCompletedDiabetic FootIran, Islamic Republic of
-
NICHD Pelvic Floor Disorders NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedFecal Incontinence | Bowel IncontinenceUnited States
-
McGuire Research InstituteUnknown
-
ES Therapeutics Australia Pty LtdWithdrawn
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedCrohn's Disease | Ulcerative Colitis | Inflammatory Bowel Disease